These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6874726)

  • 41. Cytotoxicity of receptor-mediated 16 alpha-[125I]iodoestradiol in cultured MCF-7 human breast cancer cells.
    McLaughlin WH; Milius RA; Pillai KM; Edasery JP; Blumenthal RD; Bloomer WD
    J Natl Cancer Inst; 1989 Mar; 81(6):437-40. PubMed ID: 2918551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 44. Iodine-125-labelled tamoxifen is differentially cytoxic to cells containing oestrogen receptors.
    Bloomer WD; McLaughlin WH; Weichselbaum RR; Tonnesen GL; Hellman S; Seitz DE; Hanson RN; Adelstein SJ; Rosner AL; Burstein NA; Nove JJ; Little JB
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Aug; 38(2):197-202. PubMed ID: 6968738
    [No Abstract]   [Full Text] [Related]  

  • 45. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer.
    Mariani G; Collecchi P; Giuliani L; Baranowska-Kortylewicz J; Di Luca L; Meucci G; Viacava P; Van den Abbeele AD; Salvadori PA; Di Sacco S
    Ann N Y Acad Sci; 1993 Nov; 698():204-11. PubMed ID: 8279758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and in vitro studies of [125I]IUDR-T101 antibody conjugate.
    Chakrabarti MC; Paik CH; Carrasquillo JA
    Cancer Biother Radiopharm; 1999 Apr; 14(2):91-8. PubMed ID: 10850292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. Differences with anti-estrogen and estrogen.
    Eckert RL; Katzenellenbogen BS
    J Biol Chem; 1982 Aug; 257(15):8840-6. PubMed ID: 7096337
    [No Abstract]   [Full Text] [Related]  

  • 48. Tissue distribution of the radiolabeled antiestrogen [125I]iodotamoxifen.
    Hanson RN; Seitz DE
    Int J Nucl Med Biol; 1982; 9(2):105-7. PubMed ID: 7107123
    [No Abstract]   [Full Text] [Related]  

  • 49. Target size analysis of estrogen receptor in cultured intact cells: change in receptor structure between subconfluency and superconfluency in culture.
    Toulas C; Beauregard G; Delassus F; Thauvette L; Potier M; Bayard F; Faye JC
    Mol Cell Endocrinol; 1990 Aug; 72(2):89-94. PubMed ID: 2282975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological damage from the Auger effect, possible benefits.
    Feinendegen LE
    Radiat Environ Biophys; 1975 Jun; 12(2):85-99. PubMed ID: 1101289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotoxicity of 125I-iododeoxyuridine in pre-implantation mouse embryos.
    Narra VR; Howell RW; Thanki KH; Rao DV
    Int J Radiat Biol; 1991 Sep; 60(3):525-32. PubMed ID: 1679091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiotoxicity of intranuclear 125I atoms not bound to DNA.
    Commerford SL; Bond VP; Cronkite EP; Reincke U
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 May; 37(5):547-54. PubMed ID: 6967467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell lethality after selective irradiation of the DNA replication fork.
    Hofer KG; Warters RL
    Radiat Environ Biophys; 1985; 24(3):161-74. PubMed ID: 3929325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An in vitro 125IUdR-release assay for measuring the kinetics of cell death.
    Schneiderman MH; Hofer KG; Schneiderman GS
    Int J Radiat Biol; 1991 Feb; 59(2):397-408. PubMed ID: 1671690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iodine-123-iododeoxyuridine: a potential indicator of tumour response to treatment.
    Robins AB; Taylor DM
    Int J Nucl Med Biol; 1981; 8(1):53-63. PubMed ID: 7228519
    [No Abstract]   [Full Text] [Related]  

  • 56. Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk.
    Bloomer WD; Adelstein SJ
    Int J Nucl Med Biol; 1981; 8(2-3):171-8. PubMed ID: 7033155
    [No Abstract]   [Full Text] [Related]  

  • 57. Ratio of complex double strand break damage induced by 125IUdR and 123IUdR correlates with experimental in vitro cell killing effectiveness.
    Pomplun E; Terrissol M; Hille R
    Radiat Prot Dosimetry; 2002; 99(1-4):81-2. PubMed ID: 12194366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Auger electron emitters: insights gained from in vitro experiments.
    Makrigiorgos G; Adelstein SJ; Kassis AI
    Radiat Environ Biophys; 1990; 29(2):75-91. PubMed ID: 2187215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 125IUdR loss as a measure of tumour cell loss: influence of reutilization and influx of labelled host cells.
    Franko AJ; Kallman RF; Rapacchietta D; Kelley SD
    Br J Cancer Suppl; 1980 Apr; 4():69-73. PubMed ID: 6932948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
    Bloomer WD; Adelstein SJ
    Nature; 1977 Feb; 265(5595):620-1. PubMed ID: 859560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.